Viral persistence: HIV's strategies of immune system evasion.
about
Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent mannerAntibody vs. HIV in a clash of evolutionary titansDesigning synthetic vaccines for HIVVisualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging.Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design ImplicationsA nonself sugar mimic of the HIV glycan shield shows enhanced antigenicityStructure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopyNeutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design.Evolutionary dynamics of HIV at multiple spatial and temporal scales.Human immunodeficiency virus vaccine trialsEfficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm.FIV cross-species transmission: an evolutionary prospective.Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodiesDetailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection.Helicobacter pylori's unconventional role in health and disease.Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 InfectionsHIV-1 Transmission, Replication Fitness and Disease Progression.Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41Common threads in persistent viral infectionsEvaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activationT cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.Enhanced exposure of human immunodeficiency virus type 1 primary isolate neutralization epitopes through binding of CD4 mimetic compounds.Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strainsAntibody evasion by a gammaherpesvirus O-glycan shieldEvaluation of cynomolgus macaque (Macaca fascicularis) endogenous retrovirus expression following simian immunodeficiency virus infection.Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing.Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus.Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection.PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.Non-human primate models for AIDS vaccine research.Equivalent T cell epitope promiscuity in ecologically diverse human pathogens.The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infectionAssembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.Latency in human immunodeficiency virus type 1 infection: no easy answers.IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses.
P2860
Q24301811-3DF1CF39-6A24-4C75-9ADB-D215DB9E348FQ24536059-C8F6D4DF-0797-45D6-B6F2-A6145E0CFA4BQ26862617-BF35677D-4A85-462F-A75A-9E6D7F8DDF07Q27323244-B9A6472F-356D-483F-8E0C-3B54A31F92E2Q27657377-D8AC7461-9716-468A-82EF-102735B2B033Q27664589-53D88032-1E53-4DFA-915D-3002732315CCQ28654490-A3581B4F-ED1C-47F4-868D-FD593D3D018BQ30342455-9EE12685-0B14-4700-B58D-4DCA9DF2BE93Q30416280-07ED1C08-032B-4D24-8D1D-AF5A6DDC1043Q30424366-18DB8CA9-AAB0-4426-9675-98BEDD654E34Q31007389-CBAFB86C-86A9-491F-B9FE-AF05F6FE27B1Q31147670-E7EDF430-F0AC-48AC-AB82-9C46165CD4D4Q33262382-ABA90E2E-865E-463F-9B52-744761F727EAQ33274285-62B9E97A-75AD-4D16-939F-A19EA2456EDCQ33408773-C7E6730D-2413-49B4-8AF1-F8A66E50B2FDQ33512508-E4DEE293-6B82-4D87-9FC3-3E3966212E60Q33556039-7BFEA4CA-EF55-4511-A3FA-08A484C40D11Q33657468-15F4882D-076E-44B8-B3FC-E2053834827BQ33715552-D3FD0841-A3BB-4E5A-9803-33E24F24FD40Q33758570-2D430EA6-2A89-4B4C-B936-C54C8D18572BQ33781344-8C783435-032D-48FA-A660-75DA40B7F5CEQ33826650-C0EA1879-A34B-4ED5-8028-BB2FF6C2A0CBQ33883887-A41EFDA6-3132-4FD6-BFEE-52A9DC4AF5B6Q33892217-AA75340A-192C-43F0-A457-3E53F9E1B2A2Q33935247-A261E2B5-8828-4B30-8F66-194731832876Q33964006-CFF6DBD8-3BD1-43AC-8611-387FF5A67092Q33984358-7775BB8C-FF27-4BE6-8006-01B75B2578E5Q34082672-0D6F23CB-C0D6-4E74-8462-4B31F8055975Q34328720-D03A84A3-4568-4972-A23A-69E7A8BCA376Q34372399-82E5F90F-96E4-4996-8E62-28FE14E2EBF7Q34462440-69ADDEC4-6142-4E2D-9157-90698A266D6FQ34465724-5DF51E60-D3BE-4A0E-B462-CE531156500FQ34570624-00498DE3-DA75-4849-BA54-C29BD733B088Q34647680-ED365905-7E50-45C2-8A99-51DE942C3192Q34715769-CBD86A8F-511E-4FB2-BA8E-D7D75757C295Q34951888-30710C46-5D2F-42C8-8F62-0D806FA54B39Q34995534-D3B8C226-85D2-4E69-BF66-A712CBF1A3A6Q35023762-F1971DA1-092B-4F31-8E0C-35AF5B1DBC3DQ35044157-3FA3A786-C134-48F7-A0C2-321E302F02A8Q35106912-B8DB52E4-4B4B-4420-A66D-56817DCE5A86
P2860
Viral persistence: HIV's strategies of immune system evasion.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Viral persistence: HIV's strategies of immune system evasion.
@ast
Viral persistence: HIV's strategies of immune system evasion.
@en
Viral persistence: HIV's strategies of immune system evasion.
@nl
type
label
Viral persistence: HIV's strategies of immune system evasion.
@ast
Viral persistence: HIV's strategies of immune system evasion.
@en
Viral persistence: HIV's strategies of immune system evasion.
@nl
prefLabel
Viral persistence: HIV's strategies of immune system evasion.
@ast
Viral persistence: HIV's strategies of immune system evasion.
@en
Viral persistence: HIV's strategies of immune system evasion.
@nl
P1476
Viral persistence: HIV's strategies of immune system evasion.
@en
P2093
Ronald C Desrosiers
Welkin E Johnson
P304
P356
10.1146/ANNUREV.MED.53.082901.104053
P577
2002-01-01T00:00:00Z